Patents by Inventor Choi-Fong Cho

Choi-Fong Cho has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210353708
    Abstract: Compositions comprising peptides that bind specifically to B?g (deglycosylated brevican), and methods of use thereof to deliver therapeutic and diagnostic agents to brevican-expressing cells, e.g., cancerous cells, e.g., brain cancer cells, e.g., glioblastoma cells.
    Type: Application
    Filed: October 1, 2019
    Publication date: November 18, 2021
    Inventors: Choi-Fong Cho, Sean Edward Lawler, Mariano Sebastian Viapiano
  • Patent number: 9789213
    Abstract: Polypeptides that target and/or bind to EGFL7 or its receptor and thereby reduce EGFL7 pro-angiogenic activity are provided. In this way, the polypeptides are, in an aspect, useful in the treatment of diseases, disorders, or conditions that involve pathological angiogenesis, such as, for example, cancer.
    Type: Grant
    Filed: March 15, 2013
    Date of Patent: October 17, 2017
    Assignee: LONDON HEALTH SCIENCES CENTRE RESEARCH INC.
    Inventors: John Lewis, Choi-Fong Cho, Leonard Luyt
  • Publication number: 20150071855
    Abstract: Polypeptides that target and/or bind to EGFL7 or its receptor and thereby reduce EGFL7 pro-angiogenic activity are provided. In this way, the polypeptides are, in an aspect, useful in the treatment of diseases, disorders, or conditions that involve pathological angiogenesis, such as, for example, cancer.
    Type: Application
    Filed: March 15, 2013
    Publication date: March 12, 2015
    Applicant: LONDON HEALTH SCIENCES CENTRE RESEARCHING INC.
    Inventors: John Lewis, Choi-Fong Cho, Leonard Luyt